BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Insilico Medicine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Insilico Medicine's drugs run\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07265570-40@assetmemo.bio
DTSTAMP:20261121T005945Z
DTSTART;VALUE=DATE:20270815
DTEND;VALUE=DATE:20270816
SUMMARY:garutadustat: Phase 2 readout est. (NCT07265570)
DESCRIPTION:garutadustat\, phase 2\, Ulcerative Colitis.\nStudy: Study Eval
 uating ISM5411 Administered Orally to Subjects With Active Ulcerative Coli
 tis (BETHESDA)\nEstimated primary completion: 15 August 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/garutadustat#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07265570
URL:https://assetmemo.bio/drug/garutadustat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
